Kimberly-Clark에 대한 매도 수량은 투자자에게 Kimberly-Clark의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Kimberly-Clark (NYSE:KMB) 주식, 공매도 수량 보고

Kimberly-Clark

With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Equities

News

Previews

Tech

Trading Ideas

ABBV

AGYS

ASML

BJRI

CHKP

CHTR

CMCSA

DECK

GATX

GOOG

GOOGL

JNPR

NFLX

NXPI

ODFL

ORLY

SKYW

SPOT

TSLA

VRSN

S&amp;P 500 기업들 중 약 14%가 6월 분기 실적을 발표했으며, 더 넓은 지수를 구성하는 기업들의 혼합 실적 성장률은 여전히 ​​양호하다. 이번 주에는 기술 보고 시즌이 공식적으로 시작될 것이며, 이는 최근 주에 가파른 하락세를 보인 시장의 향방을 잠재적으로 결정할 수 있다.

테슬라, 알파벳, GM 및 포드가 이번 주 실적 발표 주도하며 상승세 유지 위해 고군분투

Kimberly-Clark Corp

KAMBI GROUP LTD ORD B by Kambi Group LTD.

Kambi Group PLC

RBC Capital analyst Nik Modi reiterates Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Outperform and maintains $165 price target.

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Outperform on Kimberly-Clark, Maintains $165 Price Target

JP Morgan analyst Andrea Teixeira maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Underweight and lowers the price target from $142 to $140.

JP Morgan Maintains Underweight on Kimberly-Clark, Lowers Price Target to $140

UBS analyst Peter Grom maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Neutral and lowers the price target from $153 to $151.

UBS Maintains Neutral on Kimberly-Clark, Lowers Price Target to $151

Goldman Sachs analyst Bonnie Herzog reiterated the Buy rating on Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) stock, <a target="_blank" href="https://www.benzinga.com/quote/KMB/analyst-ratings" rel="noreferrer noopener">with a price forecast of $152.</a>
The company reported third quarter adjusted earnings per share of $1.83, beating the street view of $1.70. Quarterly revenues of $4.952 billion<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41446271/kimberly-clark-announces-third-quarter-2024-results-and-reaffirms-2024-profit-outlook" rel="noreferrer noopener"> missed the analyst consensus of $5.048 billion.</a>
According to Herzog, Kimberly-Clark&#8217;s management efforts on productivity and the current environment are conducive to margin expansion.
The analyst projects that the market underestimates the company&#8217;s potential for gross margin growth, which should lead to healthy EPS growth despite increased reinvestments.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41453793/retail-inventory-pressures-hit-kimberly-clarks-annual-outlook-stock-slides" rel="noreferrer noopener">Retail Inventory Pressures Hit Kimberly-Clark&#8217;s Annual Outlook, Stock Slides</a>
Herzog also forecasts that Kimberly-Clark&#8217;s segment reorganization will enhance execution moving forward.
As a result, the analyst sees a favorable risk/reward scenario, with Kimberly-Clark&#8217;s improving fundamentals contrasting sharply with its deep valuation discount compared to its HPC peers, offering an attractive entry point for investors.
The analyst indicated that adjusted EBIT is expected to grow in the mid-to-high teens on a constant currency basis, with adjusted EPS also projected to rise similarly.
For the fourth quarter of 2024, organic sales growth is expected to be about 4% at the mid-point, versus Goldman Sachs&#8217; estimate of 5.0%.
The projected all-in EPS is $1.46, ranging from $1.33 to $1.60, reflecting a constant currency growth of 15% &#8211; 19%, compared to Goldman Sachs&#8217; estimate of $1.60.
Price Action: KMB shares are trading lower by 4.30% to $138.01 at last check Tuesday.
Photo via Shutterstock
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41375637/market-very-convinced-of-a-trump-win-says-stanley-druckenmiller-why-billionaire-inv" target="_blank" rel="noreferrer noopener">Market &#8216;Very Convinced&#8217; Of A Trump Win, Says Stanley Druckenmiller: Why Billionaire Investor Thinks Blue Sweep Is &#8216;Highly Unlikely&#8217;</a></li>
</ul>

Analyst Color

Markets

General

Kimberly-Clark's Growth Potential 'Underestimated,' Analyst Sees Attractive Entry Point

Wall Street traded lower for the second consecutive day on Tuesday, as investor sentiment turned cautious with the U.S. presidential election <a href="https://www.benzinga.com/topic/2024-elections">just two weeks away. </a>
Concerns over U.S. fiscal policies and potential shifts in economic direction fueled the pause in risk-taking.
The International Monetary Fund (IMF) upgraded its U.S. growth forecasts for 2024 and 2025 in the latest World Economic Outlook, while also flagging rising concerns about the country's debt trajectory, warning that with current large fiscal deficits, &#8220;the U.S. public debt is not stabilized.&#8221;
Commodities were the standout performers on Tuesday, with both metals and energy experiencing notable gains.
Gold, tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), rose 0.8%, pushing further into record territory. This increase extended its year-to-date performance to 34%, positioning gold for its strongest <a href="https://www.benzinga.com/markets/bonds/24/10/41455678/gold-on-track-for-best-year-since-1979-veteran-investor-says-sell-bonds-buy-gold">annual gain since 1979.</a> Gold miners, as represented by the VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>), rallied for the ninth consecutive session, hitting their highest levels in over four years.
Silver, tracked by the iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>), surged 2.8%, reaching levels not seen since October 2012.
Oil prices rallied nearly 3%, building on a 2% surge from Monday. U.S. Treasury yields ticked up modestly on Tuesday following Monday's spike, with the 10-year yield settling at 4.21%.
Meanwhile, the U.S. Dollar Index (DXY), tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), climbed past the 104 mark, continuing its steady ascent and eyeing a fourth consecutive week of gains.
In the cryptocurrency market, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 0.5%, dipping to around $67,000 and marking its second consecutive day of declines.
<h3 class="wp-block-heading">Tuesday&#8217;s Performance In US Major Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %change</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,907.57</td>
<td>-0.1 %</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,840.39</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,291.15</td>
<td>-0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,228.60</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:35 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent102224&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.3% to $581.79.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% lower to $429.14.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.4% to $493.29.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.5% $221.04.</li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 0.6%. The Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>) lagged, down 1.1%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Performers</h3>
General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) surged 9%, on track for its strongest session in nearly a year, after reporting stronger-than-expected earnings and announcing an additional $5 billion share buyback program extending into next year.
Other stocks reacting to earnings include: 
<ul>
<li>Southern Copper Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>), up 1.5%</li>
<li>Nucor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>), down 6%</li>
<li>W.R. Berkley Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>), down 4.6%</li>
<li>Zion Bancorp. N.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>), up 6.8%</li>
<li>Wintrust Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>), up 1.6%</li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), up 8.8%</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), down over 8%</li>
<li>Danaher Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), down 3%</li>
<li>Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), down 4.4%</li>
<li>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), down 0.4%</li>
<li>Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), down 5.8%</li>
<li>Fiserv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>), down 0.4%</li>
<li>Moodys Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) down 4.5%</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), down 0.9%</li>
<li>Freeport-McMoran Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), up 1.4%</li>
<li>Kimberly-Clark Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>), down 4%</li>
<li>PulteGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>), down 5.7%</li>
</ul>
Large-cap companies reporting earnings after the close include Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), Seagate Technology Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>), Manhattan Associates Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), East West Bancorp. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) and Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>)
Now Read:
<ul>
<li><a href="https://www.benzinga.com/government/24/10/41455013/how-us-elections-could-impact-us-dollar-goldman-sachs-expects-greenback-will-remain-stronger-for-lon">How US Elections Could Impact US Dollar: Goldman Sachs Expects Greenback Will Remain &#8216;Stronger For Longer&#8217;</a></li>
</ul>
Image: Shutterstock

Earnings

Large Cap

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

New ETFs

Commodities

Currency ETFs

Small Cap

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ENPH

EWBC

Market Vectors ETF Trust Market Vectors Gold Miners

MANH

SCCO

PowerShares DB US Dollar Index Bullish Fund

WTFC

ZION

Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday?

WIIM

Kimberly-Clark shares are trading lower after the company reported worse-than-expected Q3 revenue results and cut its FY24 organic net sales guidance, citing headwinds from changes in retail inventory levels.

Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) shares are<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener"> trading lower on Tuesday.</a>
The company reported third quarter adjusted earnings per share of $1.83, beating the street view of $1.70. Quarterly revenues of $4.952 billion<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41446271/kimberly-clark-announces-third-quarter-2024-results-and-reaffirms-2024-profit-outlook" rel="noreferrer noopener"> missed the analyst consensus of $5.048 billion.</a>
Quarterly sales were down 4%, with organic sales growth of 1% versus the prior year.
Kimberly-Clark&#8217;s quarterly adjusted gross margin was 36.7%, up 90 basis points versus the prior year, driven by strong gross productivity gains.
The company&#8217;s volume and mix were positive in Developed Markets (representing&nbsp;Australia,&nbsp;South Korea, and Western/Central Europe), offset by a decline in&nbsp;North America,&nbsp;while volumes in Developing and Emerging (D&amp;E) markets were in line with the year-ago period.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41447996/us-stocks-remains-on-edge-ahead-of-flurry-of-earnings-from-lockheed-martin-gm-and-others-this-is-st" rel="noreferrer noopener">US Stocks Remains On Edge Ahead Of Flurry Of Earnings From Lockheed Martin, GM And Others: This Is Still A &#8216;Buy The Dip&#8217; Market, Says Expert</a>
Quarterly adjusted operating profit increased by 5% despite an unfavorable impact of 4 percentage points from currency translation that was primarily driven by hyperinflationary economies.
Excluding currency impacts, growth in adjusted operating profit reflected gross productivity gains, relatively neutral&nbsp;pricing net of cost inflation, supply chain related investments, as well as planned increases in marketing, research and general expenses.
Personal Care sales were $2.6 billion, down 2%, but organic sales in the segment grew 3% due to pricing actions in inflationary markets and better product mix, with volume steady across all markets.
Consumer Tissue sales were $1.5 billion, also down 2%, with segmental organic sales declining by 1%.
KCP sales fell 10% to $767 million due to divestitures and unfavorable currency effects.
The company exited the quarter with cash and equivalents worth $1.11 billion. Inventories as of quarter-end was $1.937 billion.
FY24 Outlook: The company expects organic net sales to grow by 3%-4%, down from a mid-single-digit rate, mainly due to changes in retail inventory levels. Reported net sales will still be negatively affected by 400 basis points from currency translation and 120 basis points from divestitures.
Adjusted operating profit and adjusted earnings per share are expected to grow at a mid-to-high teens percentage rate in constant currency.
Reported operating profit and reported earnings per share are now projected to be negatively impacted by about 650 basis points from currency translation, an improvement from the previous expectation of 700 basis points.
Price Action: KMB shares are trading lower by 5.12% to $136.83 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41445510/tesla-shareholders-demand-answers-from-elon-musk-on-growing-list-of-promises-ahead-of-q3-earning" target="_blank" rel="noreferrer noopener">Tesla Shareholders Demand Answers From Elon Musk On Growing List Of Promises Ahead Of Q3 Earnings: From Affordable Models To FSD Rollout And Next-Generation Roadster</a></li>
</ul>

Guidance

Movers

Retail Inventory Pressures Hit Kimberly-Clark's Annual Outlook, Stock Slides

Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate of $1.70 by 7.65 percent. This is a 5.17 percent increase over earnings of $1.74 per share from the same period last year. The company reported quarterly sales of $4.952 billion which missed the analyst consensus estimate of $5.048 billion by 1.89 percent. This is a 3.51 percent decrease over sales of $5.132 billion the same period last year.

Earnings Beats

Earnings Misses

CORRECTION: Kimberly-Clark Q3 2024 Adj. EPS $1.83 Beats $1.70 Estimate, Sales $4.952B Miss $5.048B Estimate

Kimberly-Clark Says Reported Operating Profit And EPS Are Now Expected To Be Negatively Impacted By Approximately 650 Basis Points From Currency Translation Versus A Previous Expectation Of 700 Basis Points

Kimberly-Clark Says Adjusted Operating Profit And Adjusted EPS Are Still Expected To Grow At A Mid-To-High Teens Percentage Rate On A Constant-Currency Basis

Reported Net Sales are still expected to be negatively impacted by 400 basis points of currency translation and 120 basis points from divestitures.

Kimberly-Clark Says 2024 Organic Net Sales Are Expected To Grow Between 3%-4% Versus A Mid-single Digit Rate Previously, Primarily Reflecting Discrete Headwinds From Changes In Retail Inventory Levels

Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) is preparing to release its quarterly earnings on Tuesday, 2024-10-22. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Kimberly-Clark to report an earnings per share (EPS) of $1.70.
The announcement from Kimberly-Clark is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Historical Earnings Performance</h3>
The company's EPS beat by $0.25 in the last quarter, leading to a 3.41% increase in the share price on the following day.
Here's a look at Kimberly-Clark's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.71</td>
<td>1.63</td>
<td>1.54</td>
<td>1.59</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.96</td>
<td>2.01</td>
<td>1.51</td>
<td>1.74</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>1.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729526472_0.png" alt="eps graph" />
<h3>Tracking Kimberly-Clark's Stock Performance</h3>
Shares of Kimberly-Clark were trading at $145.41 as of October 18. Over the last 52-week period, shares are up 19.84%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Observations about Kimberly-Clark</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Kimberly-Clark.
The consensus rating for Kimberly-Clark is Neutral, based on 7 analyst ratings. With an average one-year price target of $147.86, there's a potential 1.68% upside.
<h3>Peer Ratings Comparison</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Church &amp; Dwight Co, Clorox and Colgate-Palmolive, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Church &amp; Dwight Co received a Underperform consensus from analysts, with an average 1-year price target of $103.58, implying a potential 28.77% downside.</li>
<li>The prevailing sentiment among analysts is an Neutral trajectory for Clorox, with an average 1-year price target of $152.42, implying a potential 4.82% upside.</li>
<li>The prevailing sentiment among analysts is an Buy trajectory for Colgate-Palmolive, with an average 1-year price target of $108.58, implying a potential 25.33% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
The peer analysis summary offers a detailed examination of key metrics for Church &amp; Dwight Co, Clorox and Colgate-Palmolive, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kimberly-Clark</td>
<td>Neutral</td>
<td>-2.05%</td>
<td>$1.81B</td>
<td>49.91%</td>
</tr>
<tr>
<td>Church &amp; Dwight Co</td>
<td>Underperform</td>
<td>3.92%</td>
<td>$712.10M</td>
<td>5.79%</td>
</tr>
<tr>
<td>Clorox</td>
<td>Neutral</td>
<td>-5.75%</td>
<td>$884M</td>
<td>103.10%</td>
</tr>
<tr>
<td>Colgate-Palmolive</td>
<td>Buy</td>
<td>4.89%</td>
<td>$3.07B</td>
<td>414.16%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Kimberly-Clark ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, Kimberly-Clark is at the top.
<h3>Discovering Kimberly-Clark: A Closer Look</h3>
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>Financial Insights: Kimberly-Clark</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Kimberly-Clark faced challenges, resulting in a decline of approximately -2.05% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Kimberly-Clark's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.82% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Kimberly-Clark's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 49.91%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Kimberly-Clark's ROA stands out, surpassing industry averages. With an impressive ROA of 3.17%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Kimberly-Clark's debt-to-equity ratio is below the industry average. With a ratio of 7.01, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/KMB/earnings">To track all earnings releases for Kimberly-Clark visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What to Expect from Kimberly-Clark's Earnings

Barclays analyst Lauren Lieberman maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Equal-Weight and raises the price target from $135 to $144.

Barclays Maintains Equal-Weight on Kimberly-Clark, Raises Price Target to $144

8 analysts have shared their evaluations of Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $145.12, a high estimate of $165.00, and a low estimate of $134.00. This upward trend is apparent, with the current average reflecting a 3.24% increase from the previous average price target of $140.57.
<img src="https://www.benzinga.com/files/images/story/2024/1728658863_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Kimberly-Clark by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$142.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$147.00</td>
<td>$146.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$142.00</td>
<td>$139.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$134.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Buy</td>
<td>$161.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$135.00</td>
<td>$123.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$135.00</td>
<td>$136.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Kimberly-Clark. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Kimberly-Clark compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Kimberly-Clark's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Kimberly-Clark's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/KMB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Kimberly-Clark analyst ratings.</a>
<h2>Get to Know Kimberly-Clark Better</h2>
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>A Deep Dive into Kimberly-Clark's Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Kimberly-Clark's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -2.05% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Kimberly-Clark's net margin excels beyond industry benchmarks, reaching 10.82%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Kimberly-Clark's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 49.91%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Kimberly-Clark's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.17% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 7.01.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Peeling Back The Layers: Exploring Kimberly-Clark Through Analyst Insights

JP Morgan analyst Andrea Teixeira maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Underweight and raises the price target from $137 to $142.

JP Morgan Maintains Underweight on Kimberly-Clark, Raises Price Target to $142

Deutsche Bank analyst Steve Powers maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Hold and raises the price target from $146 to $147.

Deutsche Bank Maintains Hold on Kimberly-Clark, Raises Price Target to $147

McCormick &amp; Company, Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkc#NYSE">MKC</a>) reported solid third-quarter fiscal 2024 results, wherein the top and bottom lines beat the Zacks Consensus Estimate, and earnings increased year over year.
The company achieved a significant milestone by delivering overall global positive volume growth in the quarter, indicating improving trends across both business segments. The momentum is expected to carry into the fourth quarter. In the Consumer segment, MKC recorded solid volume growth despite facing a challenging macroeconomic environment in China. Meanwhile, in the Flavor Solutions segment, sequential volume improvements were realized, driven by strong growth in Branded Foodservice.
Management continues to bolster its position across major markets and core categories by focusing on growth levers such as brand marketing, product and packaging innovation, category management and proprietary technology. The company expects its cost-saving initiatives to help fund future investments and drive operating margin expansion. The year-to-date results, combined with strategic growth plans, reinforce confidence in achieving the mid-to-high range of projected sales growth for 2024.
<div class="chart_embed">
<h3>McCormick &amp; Company, Incorporated Price, Consensus and EPS Surprise 
<img alt="McCormick &amp; Company, Incorporated Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/ae/1727790166.png" style="height:265px; width:576px" title="" /></h3>
McCormick &amp; Company, Incorporated price-consensus-eps-surprise-chart | McCormick &amp; Company, Incorporated Quote
</div>
<h2>MKC&#39;s Quarterly Performance: Key Metrics and Insights</h2>
Adjusted earnings of 83 cents per share increased from 65 cents reported in the year-ago quarter. The metric came above the Zacks Consensus Estimate of 68 cents per share, representing a surprise of 22.1%. The year-over-year upside can be attributed to greater operating profit, the timing of a specific tax benefit and increased income from unconsolidated operations, fueled by robust performance from McCormick de Mexico, the company&#39;s largest joint venture.
This global leader in flavor generated sales of $1,679.8 million, flat year over year, including minimum impacts from currency movements. Impacts from the company&#39;s strategic decision to divest its canning business were offset by a 1% increase in volume backed by the Consumer segment, somewhat negated by pricing. The top line exceeded the Zacks Consensus Estimate of $1,664 million.
McCormick&#39;s gross profit margin expanded 170 basis points. The upside can be attributed to improved mix and cost savings from the Comprehensive Continuous Improvement&nbsp;program.
The adjusted operating income came in at $288 million, up 15% year over year, reflecting gross margin expansion and reduced SG&amp;A expenses.
<h2>Decoding MKC&#39;s Segmental Performance</h2>
Consumer: Sales remained flat year over year at $937.4 million, with a negligible impact on currency movements. Sales were hurt by a 1% decline from pricing actions, offset by 1% volume growth. Volume growth in the Americas and the Europe, Middle East, and Africa (&quot;EMEA&quot;) regions was partly negated by declines in the Asia-Pacific region (APAC). Sales remained flat year over year in the Americas while moving up 3% in the EMEA region. Segment sales dipped 1% in the APAC.
Flavor Solutions: Sales in the segment inched down 1% to $742.4 million. On a constant-currency basis, sales were flat year over year as a 1% rise in pricing was countered by the company&#39;s strategic move to sell off its canning business. Flavor Solutions&#39; sales in the Americas grew 2%. Flavor Solutions&#39; sales in the EMEA fell by 8%. Sales in the APAC market fell 1% year over year.
<h2>MKC&#39;s Financial Health Snapshot</h2>
McCormick exited the quarter with cash and cash equivalents of $200.8 million, long-term debt of $3,343.1 million and total shareholders&#39; equity of $5,451 million. In the nine months ended Aug. 31, 2024, net cash provided by operating activities was $463.2 million.
<h2>What to Expect From MKC in 2024?</h2>
For fiscal 2024, McCormick is focused on strengthening its volume trends and prioritizing investments to fuel profits. The company&#39;s CCI and Global Operating Effectiveness programs are driving growth investments and operating margin expansion. Management anticipates currency movements to have a minimal impact on 2024 results.
For 2024, management expects sales to range between a 1% decline and 1% growth, including minimal currency impacts. The company anticipates witnessing a favorable impact of pricing actions undertaken in the prior year. Volume trends are likely to improve due to solid brands and targeted investments. However, its decision to discontinue the low-margin business and sell the canning business is likely to put some pressure on volume during 2024.
Management expects adjusted operating income to grow 4-6%, including minimal currency impacts. This is likely to be driven by gross margin expansion, somewhat offset by a major rise in brand marketing investments.
Management envisions 2024 adjusted EPS in the band of $2.85-$2.90, which suggests a 5-7% increase from the year-ago period, including minimal currency impacts. On a GAAP basis, McCormick projects 2024 earnings in the range of $2.81- $2.86 per share compared with the year-ago period figure of $2.52.
This Zacks Rank #2 (Buy) stock has rallied 17.2% in the past three months compared with the industry&#39;s growth of 8.8%.
<h2>Other Top Staple Stocks</h2>
Here, we have highlighted three other top-ranked consumer staple stocks &mdash; The Chef&#39;s Warehouse (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chef#NASDAQ">CHEF</a>), Flowers Foods (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/flo#NYSE">FLO</a>) and Kimberly-Clark Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kmb#NYSE">KMB</a>).
The Chef&#39;s Warehouse, which engages in the distribution of specialty food products, currently sports a Zacks Rank #1 (Strong Buy).
CHEF has a trailing four-quarter earnings surprise of 33.7%, on average. The Zacks Consensus Estimate for The Chef&#39;s Warehouse&#39;s current fiscal year sales and earnings indicates growth of 9.7% and 12.6%, respectively, from the year-ago reported numbers.
Flowers Foods, one of the largest producers of packaged bakery foods in the United States, currently carries a Zacks Rank #2. FLO has a trailing four-quarter earnings surprise of 1.9%, on average.
The Zacks Consensus Estimate for Flowers Foods&#39; current financial-year sales and earnings implies growth of around 1% and 5%, respectively, from the year-ago reported numbers.
Kimberly-Clark is a personal care and consumer tissue product company that currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for Kimberly-Clark&#39;s current fiscal-year earnings indicates an advancement of 10.4% from the year-ago reported figure. KMB has a trailing four-quarter earnings surprise of 12.6%, on average.
<a href="https://www.zacks.com/stock/news/2344136/mccormick-q3-earnings-top-estimates-mkc-volumes-improve-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2344136">To read this article on Zacks.com click here.</a>

Management

CHEF

McCormick Q3 Earnings Top Estimates, MKC Volumes Improve Y/Y

Asset Sales

Global

Kimberly-Clark Is Said To Mull Options For International Tissue Business; Says Review At Early Stage, May Not Lead To Deal

<ul>
<li>New TCT agreements contribute to supporting America's clean energy transition through tax credit transferability under the Inflation Reduction Act (IRA).</li>
<li>Projects are helping to pave the way for additional investments from the voluntary market to support developers fostering renewable energy projects.</li>
<li>Through strategic guidance from Schneider Electric, Kimberly-Clark will fund four new battery energy storage projects, demonstrating its support of critical grid resiliency.</li>
</ul>
BOSTON, Sept. 23, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4260781-1&amp;h=1845358604&amp;u=https%3A%2F%2Fwww.se.com%2Fus%2Fen%2F&amp;a=Schneider+Electric">Schneider Electric</a>,&nbsp;the global leader in the digital transformation of energy management and automation, today announced having facilitated several new TCT deals by <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4260781-1&amp;h=3439761111&amp;u=https%3A%2F%2Fwww.kimberly-clark.com%2Fen-us&amp;a=Kimberly-Clark">Kimberly-Clark</a> Corporation, one of the world's leading manufacturers of personal care and hygiene products and owner of household brands such as Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, and WypAll.
Since 2016, Schneider Electric has served as a strategic advisor to Kimberly-Clark in the manufacturer's ambitious decarbonization goals. These include a commitment to reduce absolute GHG emissions by 50% (1) by 2030 and progressing towards 100% renewable electricity in North America by 2030.
Most recently, Schneider Electric acted as a strategic advisor to Kimberly-Clark to help fund multiple battery energy storage projects as part of the rapid energy transition to green America's grid. These TCT deals represent one of the many approaches Kimberly-Clark is taking to advance sustainable solutions. The projects also serve as leading examples of how the voluntary market can support developers fostering key projects using the IRA's new tax credit transferability mechanism.
The work on these collective projects supports the advancement of battery energy storage in the Texas, USA, region, aligned with Kimberly-Clark's support of the green transition in renewable energy storage and generation. Kimberly-Clark's current vPPAs produce clean power from wind in Texas, which makes up <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4260781-1&amp;h=320883471&amp;u=https%3A%2F%2Fwww.epa.gov%2Fgreenpower%2Fgreen-power-partnership-national-top-100&amp;a=40%25+of+its+total+electricity+use+by+U.S.+operations+in+renewable+energy">40% of its total electricity use by U.S. operations in renewable energy</a> that Schneider Electric has advised on.
Details of the new Investment Tax Credit Transfer agreements include:
<ul>
<li>A $82.5M TCT agreement, a 180 MW battery energy storage facility</li>
<li>A $68M TCT agreement, a 100 MW battery energy storage facility</li>
<li>A $55M TCT agreement, a 100 MW battery energy storage project
<ul>
<li>A $32M TCT agreement, a 100MW battery energy storage facility</li>
</ul>
</li>
</ul>

Schneider Electric & Kimberly-Clark Announce Tax Credit Transfer Agreements To Advance Grid Resiliency

The FDA is addressing concerns about tampon safety following a 2024 study that discovered metals in tampons during laboratory testing.
Some of the tampon makers include Procter &amp; Gamble Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), Edgewell Personal Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>), and Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>).
A&nbsp;<a target="_blank" href="https://www.sciencedirect.com/science/article/pii/S0160412024004355" rel="noreferrer noopener">study</a> published in July&nbsp;found a variety of metals, including arsenic, &nbsp;cadmium, and lead, in more than&nbsp;a dozen brands of tampons.
The researchers said they evaluated the concentrations of 16 metal(loid)s in 30 tampons from 14 tampon brands and 18 product lines.
The FDA reassured the public that all tampons must meet strict safety and effectiveness requirements before they can be legally sold in the U.S. Tampon manufacturers are required to conduct thorough tests of their products and component materials throughout the manufacturing process.
This includes pre-market biocompatibility testing, which the FDA evaluates.
While the study identified the presence of metals in certain tampons, it did not examine whether these metals are released during use or absorbed by the vaginal lining, nor did it explore the potential for metals entering the bloodstream.
In response, the FDA has <a target="_blank" href="https://www.fda.gov/medical-devices/medical-device-regulatory-science-research-programs-conducted-osel/biocompatibility-and-toxicology-program-research-medical-devices-biocompatibility-and-toxicology" rel="noreferrer noopener">launched</a> two initiatives to investigate the issue further.
<ul>
<li>First, the FDA has commissioned an independent review of the available literature on tampon safety. This review aims to enhance the agency&#8217;s understanding of existing data on the chemicals found in tampons and any associated health risks.</li>
<li>Second, the FDA has begun its internal laboratory study to measure how much metals are released from tampons under conditions mimicking typical use.</li>
</ul>
The findings from these studies will contribute to a comprehensive risk assessment of metal exposure from tampons. The FDA plans to share the results of its literature review and lab tests with the public once they have been peer-reviewed.
Additionally, the FDA emphasized that it will continue to monitor tampon safety as part of its total product lifecycle approach to medical devices.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40819405/adobe-shakes-up-video-editing-with-ai-powered-creation-tools-whats-on-the-cards" target="_blank" rel="noreferrer noopener">Adobe Shakes Up Video Editing With AI-Powered Creation Tools &#8211; What&#8217;s On The Cards?</a></li>
</ul>
Photo by Klymenko Mariia via shutterstock

Health Care

Media

Metals in Tampons: FDA Initiates New Safety Measures and Testing

Kimberly Clark Corp. is a global consumer products company producing tissue, personal care and health care brands.

Kimberly-Clark Co. (KMB) Dividend Stock Analysis

Stocks with cheap implied volatility – JPM

SDY: Dividend Growth ETF With High Turnover And Poor Return

67 Aristocrats November Dividend Cornucopia Has 39 'Safer' And 2 Ideal Dogs

Kimberly-Clark declares $1.22 dividend

Kimberly Clark ( ($KMB) ) has issued an update. Kimberly-Clark Corporation has expanded its Board of Directors by appointing Joseph Romanelli, a se...

Kimberly-Clark Expands Board with New Appointment

In times of market volatility, consumer staples stocks offer a stable investment option due to their steady demand for essential goods. Therefore, fundamentally solid consumer goods stocks Procter & Gamble (PG), Colgate-Palmolive (CL), and Kimberly-Clark (KMB) could add stability to your portfolio. Read on... Consumer staples provide stability during economic downturns, as demand for essential goods holds steady regardless of economic conditions. Consequently, investing in fundamentally strong consumer staples stocks may be a prudent choice for investors. These stocks have low beta values, which provide stability amid shifting market dynamics.
Investing in quality consumer staples stocks like Procter &amp; Gamble (<a href="https://stocknews.com/stock/PG/">PG</a>), Colgate-Palmolive (<a href="https://stocknews.com/stock/CL/">CL</a>), and Kimberly-Clark (<a href="https://stocknews.com/stock/KMB/">KMB</a>) could be a wise choice for investors. With low beta values, these stocks offer stability even as market conditions fluctuate.
The Dow and S&amp;P 500 <a href="https://www.reuters.com/markets/us/futures-slip-markets-await-inflation-data-clues-feds-rate-path-2024-11-13/">rose slightly</a> on Wednesday, while the Nasdaq declined as October CPI data aligned with forecasts, reinforcing expectations of a potential Fed rate cut in December. The CPI rose 0.2% monthly and 2.6% annually, meeting expectations.
Amid such volatility in the broader market, consumer staples provide a resilient anchor, as demand for essential goods remains unwavering and unaffected by financial shifts. These stocks not only exhibit lower volatility but also frequently offer dividends, making them a prudent refuge for investors seeking stability and reliable income amid market uncertainty.
Further, the University of Michigan's consumer sentiment index <a href="https://apnews.com/article/consumer-sentiment-economy-election-084de7cedc2a1a51df1e96898a80da0c">declined in October</a> to 68.9, down from 70.1 in September, reflecting renewed consumer concerns about high prices. Despite these concerns, consumer spending has stayed strong, with economic growth estimated at 3.2% for Q3.
Considering these conducive trends, let's examine the <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> stocks in detail.
Stock #3: The Procter &amp; Gamble Company (<a href="https://stocknews.com/stock/PG/">PG</a>)
PG provides a wide range of packaged consumer goods for personal care, health, home, and family needs. Their products, including beauty items, grooming essentials, health care solutions, and household supplies, cater to consumers worldwide through various retail and e-commerce channels.
On October 28th, 2024, PG declared a quarterly dividend of $1.0065 per share, payable on November 15, 2024. It pays an annual dividend of $4.03, which translates to a dividend yield of 2.40% at the prevailing price levels.
During the fiscal first quarter that ended September 30, 2024, PG's total net sales were $21.74 billion. Its <a href="https://www.investopedia.com/terms/o/operatingincome.asp">operating income</a> grew marginally from the year-ago value to $5.80 billion. In addition, net earnings attributable to Procter &amp; Gamble and net earnings per common share came in at $3.96 billion and $1.6, respectively.
Analysts expect PG's EPS and revenue for the second quarter ending December 31, 2024, to increase 3% and 1.6% year-over-year to $1.89 and $21.79 billion, respectively. It surpassed the Street EPS estimates in each of the trailing four quarters, which is promising.
Over the past year, the stock has gained 9.3% to close the last trading session at $166.58. It soared 13.7% year-to-date. It has a 24-month beta of 0.24.
PG's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect its robust outlook. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.
PG has a B grade in Stability and Quality. It is ranked #22 out of 55 stocks in the <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> industry.
Beyond what we have stated above, we also have given PG grades for Growth, Value, Momentum, and Sentiment. Get all the PG's ratings <a href="https://stocknews.com/stock/PG/ratings/">here</a>.
Stock #2: Colgate-Palmolive Company (<a href="https://stocknews.com/stock/CL/">CL</a>)
CL manufactures and markets a wide range of consumer products globally in oral, personal, and home care, along with pet nutrition. Key brands like Colgate, Palmolive, Softsoap, and Hill's cater to everyday needs across traditional retail, eCommerce, and professional channels for both human and pet care.
On September 12, CL declared a quarterly dividend of $0.50 per share, payable on November 15, 2024, to shareholders on record as of October 18, 2024. It pays an annual dividend of $2.00, which translates to a dividend yield of 2.20% at the prevailing price levels.
In the fiscal third quarter ended September 30, 2024, CL's total net sales increased 2.4% year-over-year to $5.03 billion. Its non-GAAP operating profit was $1.08 billion, up 4.8% from the year-ago value. Moreover, non-GAAP net income attributable to Colgate-Palmolive Company stood at $750 million and $0.91 per share, respectively, representing increases of 5.6% and 5.8% over the prior year quarter.
Street expects CL's revenue and EPS for the quarter ending December 31, 2024, to increase 2% and 3.5% year-over-year to $5.05 billion and 0.90, respectively. It surpassed the consensus EPS and revenue estimates in all trailing four quarters.
The stock has gained 14.3% year-to-date and delivered a 19.9% return over the past year, closing the last trading session at $91.07. Its 24-month beta stands at 0.24.
CL's POWR Ratings reflect strong prospects. The stock has an overall rating of B, translating to a Buy in our proprietary rating system.
It has an A grade for Quality and a B for Stability. It is ranked #18 in the same industry.
To access CL's Growth, Momentum, Sentiment, and Value ratings, click <a href="https://stocknews.com/stock/CL/ratings/">here</a>.
Stock #1: Kimberly-Clark Corporation (<a href="https://stocknews.com/stock/KMB/">KMB</a>)
KMB produces a range of personal care, consumer tissue, and professional products, including diapers, tissues, wipes, and personal protective equipment, under brands like Huggies, Kleenex, and Scott. Its products serve consumers and businesses alike through various retail, e-commerce, and other professional channels.
It pays an annual dividend of $4.88, which translates to a dividend yield of 3.70% at the prevailing price levels.
KMB posted total net sales of $4.95 billion in the fiscal 2024 third quarter that ended September 30, 2024. Its operating profit grew by 49.1% from the year-ago value to $1.15 billion. Its non-GAAP net income attributable to Kimberly-Clark Corporation and EPS stood at $617 million and $1.83, respectively, representing increases of 5.1% and 5.2% over the prior-year quarter.
Street expects KMB's EPS for the fiscal year (ending December 31, 2024) to increase 7.2% year-over-year to $7.32. Its revenue for the same period is expected to amount to $20.01 billion. In addition, it surpassed the consensus EPS estimates in three of the trailing four quarters.
Shares of KMB have gained 9.1% over the past year and 8.8% year-to-date to close the last trading session at $132.19. It has a 24-month beta of 0.29.
KMB's bright prospects are apparent in its POWR Ratings. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
It has a B grade for Value and Quality. Within the same industry, it is ranked #13.
Click <a href="https://stocknews.com/stock/KMB/ratings">here</a> to see KMB's ratings for Growth, Momentum, Sentiment, and Stability.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
PG shares rose $0.53 (+0.32%) in premarket trading Thursday. Year-to-date, PG has gained 16.51%, versus a 26.83% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Kritika Sarmah</h2> <img src='https:/wp-content/uploads/2022/08/Kritika-Sarmah_Image-3.jpg' style="float:left; padding:5px;width:125px;">Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist. She earned her bachelor's degree in commerce and is currently pursuing the CFA program. With her fundamental approach, she aims to help investors identify untapped investment opportunities.<a href="https://stocknews.com/authors/?author=kritika-sarmah">More...</a>The post <a href=https://stocknews.com/news/pg-cl-kmb-3-consumer-staples-stocks-for-stability-in-volatile-markets/>3 Consumer Staples Stocks for Stability in Volatile Markets</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Consumer Staples Stocks for Stability in Volatile Markets

The consumer goods market is attractive now due to rising consumer confidence, potential rate cuts, and steady demand, offering stability amid economic shifts. Therefore, value-focused investors might consider consumer goods stocks like Kimberly-Clark (KMB), ACCO Brands (ACCO), and Ennis (EBF). Read more... Consumer resilience is on the rise, with confidence and spending power rebounding since early 2024. This shift is benefiting the consumer goods sector, as spending moves from cautious to intentional, with a focus on essential and value-driven purchases.
In this favorable landscape, frugal investors might consider fundamentally strong consumer goods stocks like Kimberly-Clark Corporation (<a href="https://stocknews.com/stock/KMB/">KMB</a>), ACCO Brands Corporation (<a href="https://stocknews.com/stock/ACCO/">ACCO</a>), and Ennis, Inc. (<a href="https://stocknews.com/stock/EBF/">EBF</a>).
This December, the U.S. Federal Reserve is expected to cut interest rates by <a href="https://www.reuters.com/markets/rates-bonds/major-brokerages-expect-25-bps-fed-rate-cuts-november-2024-11-07/">25 basis points</a>, potentially boosting the stock market by lowering borrowing costs and encouraging equity investments. This rate cut could foster a favorable environment for consumer goods firms, making it an opportune time to consider investments in this sector as demand rises.
Meanwhile, consumer sentiment reached a six-month high in November, <a href="https://www.barrons.com/livecoverage/stock-market-today-110824/card/consumer-sentiment-climbs-to-highest-reading-in-half-a-year-TORvZB3mx18M3psVpkEO">rising to 73</a> from 70.5 in October, signaling increased confidence and potential for higher spending. With inflation expectations easing, the consumer goods market could see a boost from this renewed optimism and stronger product demand.
Furthermore, according to Statista, the consumer goods market is projected to reach $2.80 trillion in 2024, with an expected <a href="https://www.statista.com/outlook/io/manufacturing/consumer-goods/worldwide">CAGR of 1.19%</a> from 2024 to 2029. This sector could offer a stable investment choice, as companies in consumer goods generally experience consistent product demand, helping them sustain margins even in varying economic conditions.
Considering these conducive trends, let's analyze the fundamental aspects of the three <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> picks, beginning with the third choice.
Stock #3: Kimberly-Clark Corporation (<a href="https://stocknews.com/stock/KMB/">KMB</a>) 
KMB and its subsidiaries manufacture and market personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional.
In terms of forward GAAP <a href="https://www.investopedia.com/terms/p/price-earningsratio.asp">P/E</a>, KMB's 17.31x is 11.8% lower than the 19.62x industry average.
In the third quarter that ended September 30, 2024, KMB's total net sales were $4.95 billion. The company's operating profit came in at $1.15 billion, up 49.1% year-over-year. Furthermore, its adjusted net income attributable to KMB and adjusted EPS rose 5.1% and 5.2% from the prior year's quarter to $617 million and $1.83, respectively.
Analysts expect KMB's EPS for the quarter ending March 31, 2025, to increase 2% year-over-year to $2.05. Its revenue for fiscal 2025 is expected to grow marginally year-over-year to $20.08 billion. It surpassed the consensus EPS estimates in three of the trailing four quarters. KMB's stock has gained 11.3% over the past nine months to close the last trading session at $131.98.
KMB's robust outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. It has an overall rating of B, equating to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
It has a B grade for Value and Quality. Within the <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> industry, it is ranked #13 out of 55 stocks. To access KMB's grades for Growth, Momentum, Stability, and Sentiment, <a href="https://stocknews.com/stock/KMB/">click here</a>.
Stock #2: ACCO Brands Corporation (<a href="https://stocknews.com/stock/ACCO/">ACCO</a>)
ACCO designs, manufactures, and markets consumer, school, technology, and office products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International.
On November 14, 2024, ACCO announced Swingline's new collaboration with artist Leah Bisch, unveiling two stylish metal stapler designs, Wildflowers and Tan Tiles. These staplers combine functionality with Bisch's vibrant floral artistry, now available on Amazon, Swingline.com, and soon on Staples.com.
In terms of forward EV/EBITDA, ACCO's 6.41x is 48.6% lower than the 12.48x industry average. Likewise, its 6x forward non-GAAP P/E is 71.7% lower than the 21.19x industry average. Also, its 7.69x forward EV/EBIT is 56.7% lower than the 17.76x industry average.
ACCO's net sales for the third quarter ending September 30, 2024, were $420.90 million. The company's non-GAAP operating income was $44.70 million, and its non-GAAP net income was $22.50 million. Additionally, its non-GAAP earnings per share were $0.23.
For the quarter ending December 31, 2024, ACCO's EPS is expected to grow 5.1% year-over-year to $0.41. Its revenue for the quarter ending March 31, 2025, is expected to rise 1.1% year-over-year to $362.80 million. It surpassed the Street EPS estimates in each of the trailing four quarters. Over the past year, the stock has gained 28.8% to close the last trading session at $6.09.
ACCO's strong fundamentals are reflected in its POWR Ratings. It has an overall rating of B, equating to a Buy in our proprietary rating system.
It has a B grade for Growth, Value, and Sentiment. It is ranked #2 in the same industry. To see ACCO's Momentum, Stability, and Quality ratings, <a href="https://stocknews.com/stock/ACCO/">click here</a>.
Stock #1: Ennis, Inc. (<a href="https://stocknews.com/stock/EBF/">EBF</a>)
EBF manufactures and sells business forms and other business products in the United States. The company offers snap sets, continuous forms, laser-cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products.
In terms of forward EV/Sales, EBF's 1.14x is 44.4% lower than the 2.04x industry average. Its 8.55x forward EV/EBIT is 51.8% lower than the 17.76x industry average. Likewise, its 13.92x forward non-GAAP P/E is 34.3% lower than the 21.19x industry average.
During the second quarter ending on August 31, 2024, EBF reported net sales of $99.04 million, with a gross profit of $29.78 million. The company's net earnings were $10.31 million, or $0.40 per share, for the quarter. Furthermore, the company's total assets stood at $406.81 million as of August 31, 2024, compared to $399.19 million as of February 29, 2024.
EBF's stock has gained 8.4% over the past nine months to close the last trading session at $21.45.
EBF's solid prospects are reflected in its POWR Ratings. It has an overall rating of B, translating to a Buy in our proprietary rating system.
It has an A grade for Quality. It is ranked #3 in the Consumer Goods industry. Beyond what we stated above, we also have given EBF grades for Growth, Value, Momentum, Stability, and Sentiment. Get all the EBF's ratings <a href="https://stocknews.com/stock/EBF/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
KMB shares were trading at $131.68 per share on Thursday afternoon, down $0.51 (-0.39%). Year-to-date, KMB has gained 11.34%, versus a 26.01% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Abhishek Bhuyan</h2> <img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;">Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.<a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a>The post <a href=https://stocknews.com/news/kmb-ebf-acco-3-value-stocks-in-consumer-goods-for-the-frugal-investor/>3 Value Stocks in Consumer Goods for the Frugal Investor</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Value Stocks in Consumer Goods for the Frugal Investor

Dividend Roundup: Nike, Home Depot, Chevron, Target, and more

AAPL

ACCO

ALLY

AMAT

AMCR

AVGO

CHRW

DGRO

DGRW

DXCM

FANG

INTC

ISRG

KLAC

KVUE

LRCX

MSFT

NOBL

PARA

PCAR

POOL

REGL

SBUX

SCHW

SPTM

TROW

Press Releases

Huggies® and Walgreens® Encourage Parents to Join Them in Supporting Families Struggling with Diaper Need

Depend® Brand Taps Emmitt Smith for Annual Stand Strong for Men's Health Campaign Benefitting the Prostate Cancer Foundation

Ten Teachers Named as First Prize Winners of the Heroes of the Classroom Program Presented by Kleenex®

Kimberly-Clark to Announce Third Quarter 2024 Financial Results on October 22, 2024

Huggies® Promotes Safe Sleep During Safe Sleep Awareness Month

Kimberly-Clark Announces Third Quarter 2024 Results and Reaffirms 2024 Profit Outlook

U by Kotex® Launches MaxiMalism Jeans to Help End Shame Around Periods

Lauren Brazel of Tinley Park High School Is Named the Grand Prize Winner of the Heroes of the Classroom Program Presented by Kleenex®

Kimberly-Clark Elects Joseph Romanelli to its Board of Directors

Dividends

Kimberly-Clark Declares Quarterly Dividend and Announces Date of 2024 Annual Shareholder Meeting

Comments

Kimberly-Clark

매도 수량

Kimberly-Clark (NYSE:KMB) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌